MET alterations in biphasic squamoid alveolar papillary renal cell carcinomas and clinicopathological features
Thomas Denize(Harvard University), Virginie Verkarre(Université Paris Cité), Chloé Broudin(Assistance Publique – Hôpitaux de Paris), Anne‐Paule Gimenez‐Roqueplo(Délégation Paris 5), Marie Auvray-Kuentz(Université Paris Cité), Marc‐Olivier Timsit(Université Paris Cité), Mathilde Sibony(Environmental Protection Agency), Hélène Blons(Délégation Paris 5), Arnaud Méjean(Hôpital Européen), Aurélien Morini(Université Paris Cité), Nelly Burnichon(Inserm), Tom Drossart(Inserm), Thierry Jo Molina(Hôpital Necker-Enfants Malades), Déborah Jakubowicz(Inserm), Pierre Alexandre Just(Université Paris Cité), Yann Vano(Délégation Paris 5)
Cited by 24
Related Papers
Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma
|Cancer Cell|2017|791
Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma
|Cancer Cell|2021|624
Progressive immune dysfunction with advancing disease stage in renal cell carcinoma
|Cancer Cell|2021|528
Angiotensin-converting enzyme and male fertility
|Proceedings of the National Academy of Sciences|1998|336